ArticleClinical rheumatology2024

Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus.

Maya Yamato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.